Therapeutic potential of adipose derived stromal cells for major skin inflammatory diseases
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 662 KB, PDF-dokument
Inflammatory skin diseases like psoriasis and atopic dermatitis are chronic inflammatory skin conditions continuously under investigation due to increased prevalence and lack of cure. Moreover, long-term treatments available are often associated with adverse effects and drug resistance. Consequently, there is a clear unmet need for new therapeutic approaches. One promising and cutting-edge treatment option is the use of adipose-derived mesenchymal stromal cells (AD-MSCs) due to its immunomodulatory and anti-inflammatory properties. Therefore, this mini review aims to highlight why adipose-derived mesenchymal stromal cells are a potential new treatment for these diseases by summarizing the pre-clinical and clinical studies investigated up to date and addressing current limitations and unresolved clinical questions from a dermatological and immunomodulatory point of view.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 1298229 |
Tidsskrift | Frontiers in Medicine |
Vol/bind | 11 |
Antal sider | 12 |
ISSN | 2296-858X |
DOI | |
Status | Udgivet - 2024 |
ID: 385124460